StonvexLoading…
StonvexStonvexStonvexCore line items from CON's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.16B | $1.90B | $1.84B | $1.72B |
Operating Income | $333.99M | $304.76M | $287.63M | $258.53M |
Net Income | $166.41M | $166.54M | $179.95M | $166.73M |
EPS (Diluted) | $1.30 | $1.46 | $1.73 | $1.60 |
Total Assets | $2.86B | $2.52B | $2.33B | $2.30B |
Total Liabilities | $2.44B | $2.22B | $1.16B | Not available |
Cash & Equivalents | $79.90M | $183.25M | $31.37M | $37.66M |
Free Cash Flow OCF − CapEx | $197.06M | $210.35M | $169.36M | $228.35M |
Shares Outstanding | 128.63M | 128.13M | 104.19M | 103.82M |